Connect with us

Hi, what are you looking for?

Jewish Business News


Cybereason Buys Israeli Security Analytics Company empow

Cybereason is an Israeli cybersecurity unicorn which provides protection against cyberattacks to both governments and businesses alike. Cybereason (Cyber + Reason) has just bought out fellow Israeli firm empow, a security analytics company based in Tel Aviv. The purchase price was not disclosed.

Not every successful exit for a startup comes through an IPO. This is an example of a smaller company succeeding through a buyout. What is interesting here is that the acquisition was not made by an already major firm like Checkpoint or Microsoft, but by a company that, while valued at billion, has yet to have its own exit.

empow says that they deliver an intelligent, patented AI and Natural Language Processing (NLP) solution to “reduce the noise of false positives, and let your team focus on a prioritized list of attacks that really matter. And you can accomplish this without the need to manually update or write static correlation rules.”

Cybereason states that their acquisition of empow provides them with innovative predictive response technology, a library of out-of-the-box data integrations, and top-tier engineering and product talent. The company says that they will incorporate these capabilities into the Cybereason XDR offerings to “further deliver on the company’s mission to end cyber-attacks on the endpoint, across enterprise, to everywhere the battle is taking place.”

The acquisition comes just a week after former U.S. Treasury Secretary Steve Mnuchin led a $275 million financing round in Cybereason through his new fund Liberty Strategic Capital. Cyberseason, already a unicorn, tripled its valuation with that funding to as much as $3.3 billion. So why is the company so valuable? Well, cybersecurity is more important than ever. Hackers are not only motivated by money or politics. They often just like being malicious. So even small companies need to be on their guard and be sure to properly protect their systems. In recent times several different Israeli companies were ransomware attacks by the Black Shadow hackers.

Founded in 2012, Cybereason calls itself the champion for today’s cyber defenders providing future-ready attack protection that “unifies security from the endpoint, to the enterprise, to everywhere the battle moves.” The company boasts that their Cybereason Defense Platform combines the industry’s top-rated detection and response (EDR and XDR), next-gen anti-virus (NGAV), and proactive threat hunting to deliver “context-rich analysis of every element of a Malop (malicious operation).”

“The parallels between the evolution of the Cybereason solution over the last few years and the more recent development of the empow offerings are astounding,” said Cybereason co-founder and CEO Lior Div. “When we really dug into the empow capabilities, we saw how complementary our approaches are to solving the critical security issues that organizations are struggling with, and we realized that bringing empow’s capabilities and team to Cybereason was both a sound business decision and a catalyst for further market disruption.”

“Cybereason has been recognized as a leader in the EDR and EPP space for some time, and its operation-centric approach to delivering deep contextual correlations offered by the ability to identify MalOps is defining the gold standard for XDR solutions,” said empow Founder and CEO Avi Chesla. “There was a great deal of natural synergy in everything both companies were already doing, and we are very enthusiastic about the acquisition because this is truly a case where the whole is greater than the sum of the parts.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.